Moleculin Biotech
(NASDAQ) MBRX
Moleculin Biotech Financials at a Glance
Market Cap
$12.86M
Revenue (TTM)
$0.00
Net Income (TTM)
-$30.33M
EPS (TTM)
-$28.04
P/E Ratio
-0.09
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$2.52
Volume
100,377
Open
$2.36
Price
$2.52
Volume
100,377
Open
$2.36
Previous Close
$2.50
Daily Range
$2.36 - $2.54
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$2.52
Volume
100,377
Open
$2.36
Previous Close
$2.50
Daily Range
$2.36 - $2.54
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
MBRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Moleculin Biotech
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Walter V. Klemp, CPA
Website
www.moleculin.comHeadquarters
Houston, TX 77007, US
MBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-398%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-11.11%
Dividend Yield
0.00%
Payout Ratio
-5.82%
Stock Overview
Market Cap
$12.86M
Shares Outstanding
5.34M
Volume
100.38K
Avg. Volume
174.86K
Financials (TTM)
Gross Profit
-$90.00K
Operating Income
-$25.10M
EBITDA
-$25.01M
Operating Cash Flow
-$22.74M
Capital Expenditure
$0.00
Free Cash Flow
-$22.74M
Cash & ST Invst.
$8.88M
Total Debt
$359.00K
Moleculin Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$8.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$12.86M
N/A
Market Cap/Employee
$756.51K
N/A
Employees
17
N/A
Net Income
-$12.85M
-99.6%
EBITDA
-$7.87M
-33.1%
Quarterly Fundamentals
Total Cash
$10.32M
+33.7%
Total Debt
$185.00K
-58.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$185.00K
-43.3%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.30%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
-$6.11M
-33.9%
Operating Cash Flow
-$6.11M
-33.9%